{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T18:11:15Z","timestamp":1783188675388,"version":"3.54.6"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.contraception.2023.110080","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T11:29:07Z","timestamp":1685100547000},"page":"110080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Maternal complications associated with second trimester medical abortion using mifepristone priming and subsequent misoprostol"],"prefix":"10.1016","volume":"125","author":[{"given":"Jan E.","family":"Dickinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota A.","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 31","key":"10.1016\/j.contraception.2023.110080_bib1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0968-8080(08)31371-8","article-title":"Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management","volume":"16","author":"Gemzell-Danielsson","year":"2008","journal-title":"Reprod Health Matters"},{"issue":"1","key":"10.1016\/j.contraception.2023.110080_bib2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1479-828X.2009.01117.x","article-title":"Mifepristone and second trimester pregnancy termination of fetal abnormality in Western Australia: worth the effort","volume":"50","author":"Dickinson","year":"2010","journal-title":"Aust NZ J Obstet Gynaecol"},{"issue":"6","key":"10.1016\/j.contraception.2023.110080_bib3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/GCO.0000000000000409","article-title":"Update on second trimester medical abortion","volume":"29","author":"Lerma","year":"2017","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.contraception.2023.110080_bib4","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1002\/pd.6241","article-title":"Medical termination of pregnancy for fetal anomaly at or beyond 20 weeks\u2019 gestation \u2013 what are the maternal risks?","volume":"42","author":"Stewart","year":"2022","journal-title":"Prenat Diag"},{"key":"10.1016\/j.contraception.2023.110080_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.conx.2020.100037","article-title":"Medical regimens for abortion at 12\u00a0weeks and above: a systematic review and meta-analysis","volume":"2","author":"Whitehouse","year":"2020","journal-title":"Contracept X"},{"key":"10.1016\/j.contraception.2023.110080_bib6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/oxfordjournals.humrep.a135965","article-title":"Induction of abortion in the second trimester by a combination of misoprostol and mifepristone: a randomized comparison between two misoprostol regimens","volume":"10","author":"el-Refaey","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2023.110080_bib7","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1093\/humrep\/dei196","article-title":"A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12\u201320 weeks gestation","volume":"20","author":"Tang","year":"2005","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.contraception.2023.110080_bib8","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijgo.2013.08.009","article-title":"Dosing interval of 24\u00a0hours versus 48\u00a0hours between mifepristone and misoprostol administration for mid-trimester termination of pregnancy","volume":"124","author":"Chaudhuri","year":"2014","journal-title":"Obstet Gynecol Int J"},{"key":"10.1016\/j.contraception.2023.110080_bib9","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1097\/AOG.0000000000000290","article-title":"Mifepristone and oral, vaginal, or sublingual misoprostol for second-trimester abortion: a randomized controlled trial","volume":"123","author":"Dickinson","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2023.110080_bib10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijgo.2015.02.023","article-title":"A double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol for abortion at 14\u201321 weeks of pregnancy","author":"Dabash","year":"2015","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.contraception.2023.110080_bib11","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/AOG.0000000000001688","article-title":"Simultaneous administration compared with a 24-hour mifepristone-misoprostol interval in second-trimester abortion","volume":"128","author":"Abbas","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.contraception.2023.110080_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2009.05.044","article-title":"Optimization of third-stage management after second-trimester medical pregnancy termination","volume":"201","author":"Dickinson","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2023.110080_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/ajo.13653","article-title":"Mifepristone priming and subsequent misoprostol for second trimester medical abortion in women with previous caesarean delivery","author":"Dickinson","year":"2023","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"6","key":"10.1016\/j.contraception.2023.110080_bib14","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/01.AOG.0000289577.32274.a5","article-title":"Mifepristone in second-trimester medical abortion: a randomized controlled trial","volume":"100","author":"Kapp","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.contraception.2023.110080_bib15","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/AOG.0b013e318227214e","article-title":"Mifepristone and misoprostol compared with misoprostol alone for second-trimester abortion: a randomized controlled trial","volume":"118","author":"Ngoc","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2023.110080_bib16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.contraception.2008.02.016","article-title":"Late second-trimester abortions induced with mifepristone, misoprostol and oxytocin: a report of 428 consecutive cases","volume":"78","author":"Esteve","year":"2008","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.contraception.2023.110080_bib17","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/AOG.0b013e3182932f37","article-title":"Mifepristone-misoprostol dosing interval and effect on induction abortion times: a systematic review","volume":"121","author":"Shaw","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.contraception.2023.110080_bib18","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/AOG.0b013e3181d43f42","article-title":"Effect of prior cesarean delivery on risk of second-trimester surgical abortion complications","volume":"115","author":"Frick","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2023.110080_bib19","unstructured":"Abortion care guideline. Geneva: World Health Organization;\u00a02022. Licence: CC BY-NC-SA 3.0 IGO.\u00a0https:\/\/apps.who.int\/iris\/handle\/10665\/349316."},{"issue":"4","key":"10.1016\/j.contraception.2023.110080_bib20","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.contraception.2007.06.010","article-title":"Intervention rates for placental removal following induction abortion with misoprostol","volume":"76","author":"Green","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2023.110080_bib21","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/ajo.12648","article-title":"Comparison of induction of labour regimes for termination of pregnancy, with and without mifepristone, from 20 to 41 weeks gestation","volume":"57","author":"Fyfe","year":"2017","journal-title":"Aust N Z J Obstet Gynaecol"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782423001609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782423001609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T20:22:28Z","timestamp":1757881348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782423001609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":21,"alternative-id":["S0010782423001609"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2023.110080","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maternal complications associated with second trimester medical abortion using mifepristone priming and subsequent misoprostol","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2023.110080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110080"}}